InsidersTradesSigma
Follow the 迈瑞医疗 share price and the full management transaction log of the company, a publicly traded company based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 迈瑞医疗 has published 14 insider filings. Market capitalisation: €181.7bn. The latest transaction was filed on 3 June 2026 (Purchase). Among the most active insiders: LI XITING. Every trade is openly available.
Analysts rate 迈瑞医疗 Strong Buy (bullish), based on 18 analysts. Average price target: CN¥232.51.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
14 of 14 declarations
Mindray Medical is a company focused on the development and manufacturing of medical equipment and diagnostic solutions. It is listed on the XSHE market and is known for its innovations in the healthcare sector.